Drug recall · January 19, 2022
Clobetasol Propionate Ointment USP recall
Why: Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC 51672-1259-3
- Lots / codes
Lot# AC13786, exp. date DEC 2022
- Quantity
- 96 tubes
- Company
- Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY
- Distribution
- Two distributors in UT and LA who could have further distributed to the retail level nationwide in the USA.
- Initiated
- December 15, 2021 · Voluntary: Firm initiated
- Classified
- January 18, 2022
- Reported
- January 19, 2022
- Ended
- December 4, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clobetasol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.